Podocalyxin variants and risk of prostate cancer and tumor aggressiveness

Author： Casey Graham   Neville Phillippa J.   Liu Xin   Plummer Sarah J.   Cicek Mine S.   Krumroy Lisa M.   Curran Anthony P.   McGreevy Michelle R.   Catalona William J.   Klein Eric A.   Witte John S.  

Publisher： Oxford University Press

ISSN： 1460-2083

Source： Human Molecular Genetics, Vol.15, Iss.5, 2006-03, pp. : 735-741

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Androgen receptor CAG polymorphism and prostate cancer risk

By Mononen Nina   Ikonen Tarja   Autio Ville   Rökman Annika   Matikainen Mika   Tammela Teuvo   Kallioniemi Olli-P.   Koivisto Pasi   Schleutker Johanna  

Human Genetics, Vol. 111, Iss. 2, 2002-08 ,pp. : 166-171

Springer Publishing Company

Access to resources Recommend Favorite

Quantifying the cumulative effect of low‐penetrance genetic variants on breast cancer risk

By  

Molecular Genetics & Genomic Medicine, Vol. 3, Iss. 3, 2015-05 ,pp. : 182-188

John Wiley & Sons Inc

Access to resources Recommend Favorite

Variants in the HEPSIN gene are associated with prostate cancer in men of European origin

By Pal Prodipto   Xi Huifeng   Kaushal Ritesh   Sun Guangyun   Jin Carol   Jin Li   Suarez Brian   Catalona William   Deka Ranjan  

Human Genetics, Vol. 120, Iss. 2, 2006-09 ,pp. : 187-192

Springer Publishing Company

Access to resources Recommend Favorite

Prostate cancer susceptibility locus HPC1 in Utah high-risk pedigrees

By Neuhausen Susan L.  

Human Molecular Genetics, Vol. 8, Iss. 13, 1999-12 ,pp. : 2437-2442

Oxford University Press

Access to resources Recommend Favorite

Genetic Susceptibility to Type 2 Diabetes Is Associated with Reduced Prostate Cancer Risk

By  

Human Heredity, Vol. 69, Iss. 3, 2010-03 ,pp. : 193-201

Karger

Access to resources Recommend Favorite